Lack of macrophage migration inhibitory factor protects mice against concanavalin A-induced liver injury

Liver International

Volumn 26, Issue 3, 2006, Pages 346-351

  Nakajima, Hiroaki ^a   Takagi, Hitoshi ^a   Horiguchi, Norio ^a   Toyoda, Mitsuo ^a   Kanda, Daisuke ^a   Otsuka, Toshiyuki ^a   Emoto, Yoshiko ^b   Emoto, Masashi ^b   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Concanavalin A; Interferon ; Liver; Macrophagemigration inhibitory factor; Mouse; Tumor necrosis factor

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; CD69 ANTIGEN; CONCANAVALIN A; MACROPHAGE MIGRATION INHIBITION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE HEPATITIS; CELL INFILTRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNE MEDIATED INJURY; INFLAMMATORY CELL; KNOCKOUT MOUSE; LEUKOCYTE ACTIVATION; LIVER INJURY; LIVER PARENCHYMA; LIVER PROTECTION; LYMPHOCYTE ACTIVATION; MEDIATOR; MOUSE; NECROSIS; NONHUMAN; PROTEIN FUNCTION; VIRUS HEPATITIS; WILD TYPE;

ALANINE TRANSAMINASE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BIOLOGICAL MARKERS; CONCANAVALIN A; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMATION MEDIATORS; INTERFERON TYPE II; LEUKOCYTES; LIVER; LYMPHOCYTE ACTIVATION; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MITOGENS; NECROSIS; RNA, MESSENGER; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33644789621     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2005.01216.x     Document Type: Article

References (30)

1. Tiegs G, Hentschel J, Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 1992; 90: 196-203.
2. Gantner F, Leist M, Lohse A W, Germann P G, Tiegs G. Concanavalin A-induced T-cell-mediated hepatic injury in mice: The role of tumor necrosis factor. Hepatology 1995; 21: 190-8.
3. Mizuhara H, O'Neill E, Seki N, et al. T cell activation-associated hepatic injury: Mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med 1994; 179: 1529-37.
4. Kusters S, Gantner F, Kunstle G., Tiegs G. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 1996; 111: 462-71.
5. Louis H., Le Moine O, Peny M-O, et al. Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice. Hepatology 1997; 25: 1382-9.
6. Nicoletti F, Di Marco R, Zaccone P, et al. Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-γ-dependent mechanism. Hepatology 2000; 32: 728-33.
7. Watanabe Y, Morita M, Akaike T. Concanavalin A induces perforin-mediated but not Fas-mediated hepatic injury. Hepatology 1996; 24: 702-10.
8. -/- mice. J Immunol 1997; 159: 1418-28.
9. Morita M, Watanabe Y, Akaike T. Protective effect of hepatocyte growth factor on interferon-gamma-induced cytotoxicity in mouse hepatocytes. Hepatology 1995; 21: 1585-93.
10. Ferrari C, Mondelli M U, Penna A, Fiaccadori F, Chisari F V. Functional characterization of cloned intrahepatic, hepatitis B virus nucleoprotein-specific helper T cell lines. J Immunol 1987; 139: 539-44.
11. Napoli J, Bishop G A, McGuinness P H, Painter D M, McCaughan G W. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 1996; 24: 759-65.
12. Bloom B R, Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 1966; 153: 80-2.
13. David J R. Delayed hypersensitivity on vitro: Its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci USA 1966; 56: 72-7.
14. Bernhagen J, Calandra T, Mitchell R A, et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxemia. Nature 1993; 365: 756-9.
15. Calandra T, Bernhagen J, Mitchell R A, Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 1994; 179: 1895-902.
16. Lue H, Kleemann R, Calandra T, Roger T, Bernhagen J. Macrophage migration inhibitory factor (MIF): Mechanisms of action and role in disease. Microbe Infect 2002; 4: 449-60.
17. Baugh J A, Bucala R. Macrophage migration inhibitory factor. Crit Care Med 2002; 30: S27-S35.
18. Calandra T, Bernhagen J, Metz C N, et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995; 377: 68-71.
19. Calandra T, Echtenacher B, Le Roy D, et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 2000; 6: 164-70.
20. Bozza M, Satoskar A R, Lin G, et al. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med 1999; 189: 341-6.
21. Kobayashi S, Nishihira J, Watanabe S, Todo S. Prevention of lethal acute hepatic failure by antimacrophage migration inhibitory factor antibody in mice treated with Bacille Calmette-Guerin and lipopolysaccharide. Hepatology 2000; 29: 1752-9.
22. Honma N, Koseki H, Akasaka T, et al. Deficiency of the macrophage migration inhibitory factor gene has no significant effect on endotoxaemia. Immunology 2000; 100: 84-90.
23. Horiguchi N, Takayama H, Toyoda M, et al. Hepatocyte growth factor promotes hepatocartinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine. Oncogene 2002; 21: 1791-9.
24. 2-microglobulin and NK1.1 expression. Int Immunol 1995; 7: 1729-39.
25. Bourdi M, Reilly T P, Elkahloun A G, George J W, Pohl L R. Macrophage migration inhibitory factor in drug-induced liver injury: A role in susceptibility and stress responsiveness. Biochem Biophys Res Commun 2002; 294: 225-30.
26. Ren Y, Tsui H T, Poon R T, et al. Macrophage migration inhibitory factor: Roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma. Int J Cancer 2003; 107: 22-9.
27. Zhang H Y, Nanji A A, Luk J M, et al. Macrophage migration inhibitory factor expression correlates with inflammatory changes in human chronic hepatitis B infection. Liver Int 2005; 25: 571-9.
28. Leng L, Metz C N, Fang Y, et al. MIF signal transduction initiated by binding to CD74. J Exp Med 2003; 197: 1467-76.
29. Trautwein C, Rakemann T, Malek N P, Plumpe J, Tiegs G, Manns M P. Concanavalin A-induced liver injury triggers hepatocyte proliferation. J Clin Invest 1998; 101: 1960-9.
30. Kitaichi N, Ogasawara K, Iwabuchi K, et al. Different influence of macrophage migration inhibitory factor in signal transduction pathway of various T cell subsets. Immunobiology 2000; 201: 356-67.